Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on September 8, 2020, reporting events occurring on September 4, 2020. The filing addresses a significant change in executive leadership.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
- Executive Departure: Dale Sanders notified the Company on September 4, 2020, of his decision to step down as Chief Technology Officer (CTO) to pursue other opportunities.
- Transition Plan: Mr. Sanders will remain employed full-time through September 30, 2020, to ensure a smooth transition.
- Future Role: Following his separation date, Mr. Sanders will support the Company as a senior advisor.
- Agreement: The Company and Mr. Sanders anticipate entering into a separation and consulting agreement.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the operational impact of the CTO departure. A press release regarding the transition is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the terms of the separation and consulting agreement to be entered into with Dale Sanders.
- Confirm the timeline for the appointment of a permanent successor to the CTO role.
- Review the attached press release (Exhibit 99.1) for additional details on the transition strategy.